What Caxton Associates LLP changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$5.3bn
$2.0bn at Q2 2013
Positions
730
145 at Q2 2013
Top ten weight
56%
50% at Q2 2013
Typical quarterly turnover
about 45%
Estimated from share changes
- Q2 2013: $2.0bn
- Q3 2013: $1.9bn
- Q4 2013: $3.1bn
- Q1 2014: $1.6bn
- Q2 2014: $1.9bn
- Q3 2014: $3.0bn
- Q4 2014: $1.3bn
- Q1 2015: $2.4bn
- Q2 2015: $2.2bn
- Q3 2015: $1.6bn
- Q4 2015: $628m
- Q1 2016: $1.4bn
- Q2 2016: $3.6bn
- Q3 2016: $3.0bn
- Q4 2016: $2.2bn
- Q1 2017: $25.8bn
- Q2 2017: $14.9bn
- Q3 2017: $2.8bn
- Q4 2017: $2.0bn
- Q1 2018: $2.0bn
- Q2 2018: $2.0bn
- Q3 2018: $1.5bn
- Q4 2018: $632m
- Q1 2019: $688m
- Q2 2019: $831m
- Q3 2019: $503m
- Q4 2019: $729m
- Q1 2020: $544m
- Q2 2020: $1.1bn
- Q3 2020: $950m
- Q4 2020: $1.4bn
- Q1 2021: $1.1bn
- Q2 2021: $912m
- Q3 2021: $905m
- Q4 2021: $982m
- Q1 2022: $1.2bn
- Q2 2022: $1.0bn
- Q3 2022: $751m
- Q4 2022: $1.5bn
- Q1 2023: $663m
- Q2 2023: $676m
- Q3 2023: $727m
- Q4 2023: $1.9bn
- Q1 2024: $1.8bn
- Q2 2024: $2.9bn
- Q3 2024: $2.7bn
- Q4 2024: $3.2bn
- Q1 2025: $2.9bn
- Q2 2025: $3.9bn
- Q3 2025: $4.2bn
- Q4 2025: $5.1bn
- Q1 2026: $4.4bn
- Q2 2026: $5.3bn
- Q2 2013: 50%
- Q3 2013: 47%
- Q4 2013: 44%
- Q1 2014: 43%
- Q2 2014: 51%
- Q3 2014: 50%
- Q4 2014: 50%
- Q1 2015: 54%
- Q2 2015: 56%
- Q3 2015: 65%
- Q4 2015: 56%
- Q1 2016: 67%
- Q2 2016: 52%
- Q3 2016: 55%
- Q4 2016: 50%
- Q1 2017: 94%
- Q2 2017: 88%
- Q3 2017: 37%
- Q4 2017: 26%
- Q1 2018: 46%
- Q2 2018: 47%
- Q3 2018: 38%
- Q4 2018: 64%
- Q1 2019: 39%
- Q2 2019: 47%
- Q3 2019: 58%
- Q4 2019: 51%
- Q1 2020: 57%
- Q2 2020: 60%
- Q3 2020: 72%
- Q4 2020: 77%
- Q1 2021: 62%
- Q2 2021: 60%
- Q3 2021: 52%
- Q4 2021: 45%
- Q1 2022: 62%
- Q2 2022: 58%
- Q3 2022: 48%
- Q4 2022: 72%
- Q1 2023: 37%
- Q2 2023: 36%
- Q3 2023: 32%
- Q4 2023: 36%
- Q1 2024: 53%
- Q2 2024: 55%
- Q3 2024: 64%
- Q4 2024: 63%
- Q1 2025: 53%
- Q2 2025: 57%
- Q3 2025: 62%
- Q4 2025: 58%
- Q1 2026: 56%
- Q2 2026: 56%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Warner Bros Discovery Inc(WBD)Common Series A | Q2 2022 | $518mQ2 2026 | $518m | |
| Apple Inc(AAPL) | Q4 2013 | $548mQ3 2025 | $389m | |
| Microsoft Corp(MSFT) | Q1 2014 | $479mQ1 2026 | $377m | |
| Norfolk Southern Corp(NSC) | Q2 2016 | $328mQ2 2026 | $328m | |
| Amazon Com Inc(AMZN) | Q4 2013 | $532mQ4 2024 | $321m | |
| Advanced Micro Devices Inc(AMD) | Q2 2016 | $472mQ4 2025 | $267m | |
| Select Sector SPDR Energy ETF(XLE) | Q2 2026 | $235mQ2 2026 | $235m | |
| Bp plc(BP)Sponsored ADR | Q2 2018 | $362mQ4 2025 | $216m | |
| Nvidia Corp(NVDA) | Q3 2014 | $449mQ1 2026 | $204m | |
| Alphabet Inc(GOOGL)Capital Stock Class A | Q4 2015 | $134mQ2 2026 | $134m | |
| Bank of America Corporation(BAC) | Q2 2013 | $125mQ2 2015 | $115m | |
| MP Materials Corp(MP)Common Class A | Q1 2022 | $132mQ2 2025 | $112m | |
| iShares MSCI Emerging Markets ETF(EEM) | Q1 2016 | $7.9bnQ1 2017 | Soldlast listed Q2 2022 | |
| iShares MSCI Emerging Markets ETF(EEM) | Q3 2015 | $6.9bnQ1 2017 | Soldlast listed Q1 2026 | |
| Barclays BK PLCIpath S&P500 VIX | Q1 2017 | $5.5bnQ1 2017 | Soldlast listed Q1 2017 | |
| SPDR Index SHS Euro Stoxx 50(FEZ) | Q1 2017 | $1.8bnQ1 2017 | Soldlast listed Q1 2017 | |
| Barclays BK PLCIpath S&P500 VIX | Q1 2017 | $1.6bnQ1 2017 | Soldlast listed Q2 2017 | |
| Tesla MTRS Inc(TSLA) | Q4 2013 | $975mQ4 2025 | Soldlast listed Q4 2025 | |
| Spdr S&P 500 Etf Trust(SPY) | Q2 2013 | $519mQ4 2022 | Soldlast listed Q4 2024 | |
| Spdr S&P 500 Etf Trust(SPY) | Q2 2013 | $466mQ3 2025 | Soldlast listed Q3 2025 |
Quarter by quarter
Q1 2022: $1.2bn across 495 positions
Against Q4 2021: 235 new, 118 added to, 105 trimmed, 270 sold out, across all 495 positions.
Turnover about 48% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Tesla MTRS Inc (TSLA)+$107m
- iShares Russell 2000 ETF (IWM)+$27m
- Moderna Inc (MRNA)+$13m
- Pfizer Inc (PFE)+$8.4m
- Apple Inc (AAPL)+$6.1m
- Cerner Corp+$3.1m
- Exxon Mobil Corp (XOM)+$2.9m
- American National Group Inc+$2.1m
Largest reductions
- Facebook Inc (META)-$17m
- Select Sector SPDR Energy (XLE)-$9.7m
- Amazon Com Inc (AMZN)-$8.3m
- Facebook Inc (META)-$7.7m
- Select Sector SPDR Shares Of Beneficial Interest Healthcare (XLV)-$6.7m
- Select Sector SPDR Financial (XLF)-$4.9m
- iShares Russell 2000 ETF (IWM)-$4.4m
- Equity Comwlth-$3.3m
Opened
- Freeport-mcmoran Copper & Go (FCX)$187m
- Aptiv PLC$155m
- Select Sector SPDR Energy (XLE)$23m
- Select Sector SPDR Energy (XLE)$23m
- Select Sector SPDR Financial (XLF)$19m
- Select Sector SPDR Financial (XLF)$19m
- Invesco QQQ Trust (QQQ)$18m
- Select Sector SPDR Shares Of Beneficial Interest Healthcare (XLV)$16m
Sold out
- Spdr S&P 500 Etf Trust (SPY)was $93m
- Select Sector SPDR Trust (XLB)was $44m
- United Rentals Inc (URI)was $36m
- Taiwan Semiconductor MFG LTD (TSM)was $35m
- Micron Technology Inc (MU)was $28m
- Select Sector SPDR Trust (XLC)was $16m
- Zebra Technologies Corp (ZBRA)was $15m
- Intuitive Surgical Inc (ISRG)was $13m
Largest positions, Q1 2022
The largest 25 of 495 reported positions.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Freeport-mcmoran Copper & Go (FCX) | $187m | 15.2% | New |
| Aptiv PLC | $155m | 12.6% | New |
| Pfizer Inc (PFE) | $150m | 12.2% | Added |
| Tesla MTRS Inc (TSLA) | $107m | 8.7% | Added |
| iShares Russell 2000 ETF (IWM) | $34m | 2.8% | Trimmed |
| iShares Russell 2000 ETF (IWM) | $32m | 2.6% | Added |
| Moderna Inc (MRNA) | $29m | 2.4% | Added |
| Select Sector SPDR Energy (XLE) | $23m | 1.9% | New |
| Select Sector SPDR Energy (XLE) | $23m | 1.9% | New |
| Microsoft Corp (MSFT) | $21m | 1.7% | Trimmed |
| Select Sector SPDR Financial (XLF) | $19m | 1.5% | New |
| Select Sector SPDR Financial (XLF) | $19m | 1.5% | New |
| Invesco QQQ Trust (QQQ) | $18m | 1.5% | New |
| Select Sector SPDR Shares Of Beneficial Interest Healthcare (XLV) | $16m | 1.3% | New |
| Cme Group Inc (CME) | $14m | 1.2% | Trimmed |
| Amazon Com Inc (AMZN) | $13m | 1.0% | Trimmed |
| General Electric Co (GE) | $10m | 0.8% | Held |
| VanEck Vectors Gold Miners (GDX) | $9.8m | 0.8% | New |
| iShares China Lg-capital ETF (FXI) | $8.0m | 0.7% | Added |
| iShares China Lg-capital ETF (FXI) | $8.0m | 0.7% | Held |
| iShares 20 Year Treasury Bond ETF (TLT) | $7.9m | 0.6% | New |
| Apple Inc (AAPL) | $7.6m | 0.6% | Added |
| General Electric Co (GE) | $5.2m | 0.4% | Added |
| iShares 20 Year Treasury Bond ETF (TLT) | $4.9m | 0.4% | New |
| iShares Silver Trust (SLV) | $4.8m | 0.4% | New |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| Arrowstreet Capital LP | at least 30% | 163 | Compare | |
| Invesco Ltd | at least 30% | 171 | Compare | |
| T. Rowe Price Associates Inc | at least 27% | 146 | Compare | |
| Acadian Asset Management LLC | at least 27% | 155 | Compare | |
| Fidelity (FMR LLC) | at least 25% | 126 | Compare | |
| Neuberger Berman Group LLC | at least 24% | 139 | Compare | |
| Wellington Management Group LLP | at least 23% | 136 | Compare | |
| Third Point LLC | at least 23% | 9 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Caxton Associates LLP | $5.3bn | 13F-HR | |
| Q1 2026 | Caxton Associates LLP | $4.4bn | 13F-HR | |
| Q4 2025 | Caxton Associates LLP | $5.1bn | 13F-HR | |
| Q3 2025 | Caxton Associates LLP | $4.2bn | 13F-HR | |
| Q2 2025 | Caxton Associates LLP | $3.9bn | 13F-HR | |
| Q1 2025 | Caxton Associates LLP | $2.9bn | 13F-HR | |
| Q4 2024 | Caxton Associates LP | $3.2bn | 13F-HR | |
| Q3 2024 | Caxton Associates LP | $2.7bn | 13F-HR | |
| Q2 2024 | Caxton Associates LP | $2.9bn | 13F-HR | |
| Q1 2024 | Caxton Associates LP | $1.8bn | 13F-HR | |
| Q4 2023 | Caxton Associates LP | $1.9bn | 13F-HR | |
| Q3 2023 | Caxton Associates LP | $727m | 13F-HR | |
| Q2 2023 | Caxton Associates LP | $676m | 13F-HR | |
| Q1 2023 | Caxton Associates LP | $663m | 13F-HR | |
| Q4 2022 | Caxton Associates LP | $1.5bn | 13F-HR | |
| Q3 2022 | Caxton Associates LP | $751m | 13F-HR | |
| Q2 2022 | Caxton Associates LP | $1.0bn | 13F-HR | |
| Q1 2022 | Caxton Associates LP | $1.2bn | 13F-HR | |
| Q4 2021 | Caxton Associates LP | $982m | 13F-HR | |
| Q3 2021 | Caxton Associates LP | $905m | 13F-HR | |
| Q2 2021 | Caxton Associates LP | $912m | 13F-HR | |
| Q1 2021 | Caxton Associates LP | $1.1bn | 13F-HR | |
| Q4 2020 | Caxton Associates LP | $1.4bn | 13F-HR | |
| Q3 2020 | Caxton Associates LP | $950m | 13F-HR | |
| Q2 2020 | Caxton Associates LP | $1.1bn | 13F-HR | |
| Q1 2020 | Caxton Associates LP | $544m | 13F-HR | |
| Q4 2019 | Caxton Associates LP | $729m | 13F-HR | |
| Q3 2019 | Caxton Associates LP | $503m | 13F-HR | |
| Q2 2019 | Caxton Associates LP | $831m | 13F-HR | |
| Q1 2019 | Caxton Associates LP | $688m | 13F-HR | |
| Q4 2018 | Caxton Associates LP | $632m | 13F-HR | |
| Q3 2018 | Caxton Associates LP | $1.5bn | 13F-HR | |
| Q2 2018 | Caxton Associates LP | $2.0bn | 13F-HR | |
| Q1 2018 | Caxton Associates LP | $2.0bn | 13F-HR | |
| Q4 2017 | Caxton Associates LP | $2.0bn | 13F-HR | |
| Q3 2017 | Caxton Associates LP | $2.8bn | 13F-HR | |
| Q2 2017 | Caxton Associates LP | $14.9bn | 13F-HR | |
| Q1 2017 | Caxton Associates LP | $25.8bn | 13F-HR | |
| Q4 2016 | Caxton Associates LP | $2.2bn | 13F-HR | |
| Q3 2016 | Caxton Associates LP | $3.0bn | 13F-HR | |
| Q2 2016 | Caxton Associates LP | $3.6bn | 13F-HR | |
| Q1 2016 | Caxton Associates LP | $1.4bn | 13F-HR | |
| Q4 2015 | Caxton Associates LP | $628m | 13F-HR | |
| Q3 2015 | Caxton Associates LP | $1.6bn | 13F-HR | |
| Q2 2015 | Caxton Associates LP | $2.2bn | 13F-HR | |
| Q1 2015 | Caxton Associates LP | $2.4bn | 13F-HR | |
| Q4 2014 | Caxton Associates LP | $1.3bn | 13F-HR | |
| Q3 2014 | Caxton Associates LP | $3.0bn | 13F-HR | |
| Q2 2014 | Caxton Associates LP | $1.9bn | 13F-HR | |
| Q1 2014 | Caxton Associates LP | $1.6bn | 13F-HR | |
| Q4 2013 | Caxton Associates LP | $3.1bn | 13F-HR | |
| Q3 2013 | Caxton Associates LP | $1.9bn | 13F-HR | |
| Q2 2013 | Caxton Associates LP | $2.0bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More